Home/Filings/4/0001209191-23-024497
4//SEC Filing

MANHARD KIMBERLY 4

Accession 0001209191-23-024497

CIK 0000818033other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 5:26 PM ET

Size

13.2 KB

Accession

0001209191-23-024497

Insider Transaction Report

Form 4
Period: 2023-04-13
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-13+4,56429,747 total
  • Tax Payment

    Common Stock

    2023-04-13$2.88/sh1,417$4,08128,330 total
  • Exercise/Conversion

    Common Stock

    2023-04-13+1,25025,183 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-04-131,2507,500 total
    Common Stock (1,250 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2023-04-134,56427,936 total
    Common Stock (4,564 underlying)
Footnotes (4)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
  • [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
  • [F4]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001202094

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 5:26 PM ET
Size
13.2 KB